Patient-reported outcomes for patients with metastatic castration-resistant prostate cancer receiving docetaxel and Atrasentan versus docetaxel and placebo in a randomized phase III clinical trial (SWOG S0421)

  • Joseph M. Unger (Creator)
  • Katherine Griffin (Creator)
  • Gary W. Donaldson (Creator)
  • Karen Baranowski (Creator)
  • Margorie J. Good (Contributor)
  • Eunicia Reburiano (Contributor)
  • Maha Hussain (Creator)
  • Paul Monk (Creator)
  • Peter Van Veldhuizen (Contributor)
  • Michael A. Carducci (Creator)
  • Celestia S. Higano (Contributor)
  • Primo N. Lara (Creator)
  • Catherine M. Tangen (Creator)
  • David Quinn (Creator)
  • James L. Wade (Heartland NCORP) (Creator)
  • Nicholas J. Vogelzang (Creator)
  • I. M. Thompson (Creator)
  • Carol M. Moinpour (Creator)
  • Peter Van Veldhuizen (Creator)
  • Primo Lara (Creator)
  • Catherine Tangen (Creator)
  • David Quinn (Creator)
  • Nicholas Vogelzang (Creator)
  • Ian M. Thompson (Creator)



Search results